Camille Kotton MD

Camille Nelson Kotton MD, FIDSA, FAST is the clinical director of the Transplant Infectious Disease and Immunocompromised Host Program at the Massachusetts General Hospital, and Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts. She is the past chair of The Infectious Disease Community of Practice of The American Society of Transplantation. From 2007-2013, she was the president of The Transplant Infectious Disease Section of The Transplantation Society. Highlights of her time as president include the development of international guidelines on CMV management after solid organ transplant, followed by an updated version, published in Transplantation (2010 and 2013). Her clinical interests include cytomegalovirus, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting.

Laura Dember MD

Laura M. Dember, M.D. is a Professor of Medicine and Epidemiology at the University of Pennsylvania Perelman School of Medicine where she is a faculty member in the Renal-Electrolyte and Hypertension Division and a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics.  Dr. Dember conducts patient-oriented research in chronic kidney disease and end-stage renal disease and has particular interests in hemodialysis vascular access and interventions to improve clinical outcomes for patients treated with maintenance hemodialysis.  She has leadership roles in several multicenter observational studies and clinical trials including the Dialysis Access Consortium, the Hemodialysis Fistula Maturation Study, the Hemodialysis Novel Therapies Consortium, and the TiME Trial, all funded by the US National Institutes of Health. She has clinical expertise in the systemic amyloidoses and has been involved in the development of new treatment approaches for this group of disorders.  Dr. Dember has been a member of several committees of the American Society of Nephrology and is a Deputy Editor for the American Journal of Kidney Diseases.

Charmaine E Lok MD

Charmaine E. Lok, BSc(PT), MD, MSC, FRCP(C) is a Professor of Medicine at the University of Toronto (U of T). She is graduate faculty in the Clinical Epidemiology & Health Care Research Program, Department of Health Policy, Management and Evaluation (U of T) and the Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, McMaster University. Dr. Lok is the Medical Director of both the multidisciplinary chronic kidney disease (CKD) and hemodialysis programs at the University Health Network-Toronto General Hospital, Toronto, Canada. She is a Senior Scientist at the Toronto General Research Institute with research interests in patient health outcomes and functional ability in CKD, hemodialysis vascular access and cardiovascular disease in endstage renal disease (ESRD). Dr. Lok is also active in raising awareness of CKD and ESKD and its importance in public health. She is involved in a variety of local and international scientific and educational programs, including ASN, CIHR, DOPPS, KFOC, NKF, and Kidney CARE Network International.

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the conference.
© 2015 - 2016 Conference Design Pty Ltd